StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Lipella Pharmaceuticals's cash was $1.86M at Sep 30, 2025. For fiscal 2024 it was $2.18M, down 33.7% from the year before. The highest annual figure on record is $5.12M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2024Dec 31, 2024$2.18M-33.7%
FY2023Dec 31, 2023$3.29M-35.7%
FY2022Dec 31, 2022$5.12M+198.8%
FY2021Dec 31, 2021$1.71M+182.6%
FY2020Dec 31, 2020$606.74K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$1.86M+37.1%
Q2 FY2025Jun 30, 2025$2.78M+134.5%
Q1 FY2025Mar 31, 2025$4.23M+100.7%
Q4 FY2024Dec 31, 2024$2.18M-33.7%
Q3 FY2024Sep 30, 2024$1.35M-43.8%
Q2 FY2024Jun 30, 2024$1.19M-61.9%
Q1 FY2024Mar 31, 2024$2.11M-47.6%
Q4 FY2023Dec 31, 2023$3.29M-35.7%
Q3 FY2023Sep 30, 2023$2.41M+1999.7%
Q2 FY2023Jun 30, 2023$3.11M+615.8%
Q1 FY2023Mar 31, 2023$4.02M+869.8%
Q4 FY2022Dec 31, 2022$5.12M+198.8%
Q3 FY2022Sep 30, 2022$114.77K-81.1%
Q2 FY2022Jun 30, 2022$434.98K–
Q1 FY2022Mar 31, 2022$414.40K–
Q4 FY2021Dec 31, 2021$1.71M–
Q4 FY2020Dec 31, 2020$606.74K–

More Lipella Pharmaceuticals figures

See a number that looks wrong?